Deactivating cardioverter defibrillators near the end of lifeBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f558 (Published 30 January 2013) Cite this as: BMJ 2013;346:f558
When US researchers surveyed 95 adults with implantable cardioverter defibrillators, 67 (71%) said they would consider deactivating the device when approaching the end of life. Responses to a series of scenarios varied between …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial